BUZZ-U.S. STOCKS ON THE MOVE-Supervalu, Multi-Fineline, CyberArk
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) Wall Street's early gains evaporated on Wednesday morning, led by a drop in Amazon and other consumer discretionary stocks, while crude oil prices struggled to end their losing streak. The Dow Jones industrial average was down 1.00 percent at 16,350.49, the S&P 500 was down 1.11 percent at 1,917.17 and the Nasdaq Composite was down 1.62 percent at 4,610.235.
** SAGENT PHARMA, $15.74, +18.61 pct
The U.S. generic life sciences company focusing on injectable drugs is considering a sale of the company as part of an exploration of strategic alternatives, according to people familiar with the matter.
** CHECK POINT SOFTWARE TECHNOLOGIES, $78.7, -0.06 pct
** CYBERARK SOFTWARE, $45.43, +20.06 pct
Israel cyber security firm Check Point in initial talks to buy smaller provider CyberArk - TheMarker financial newspaper.